Sleep Disorders in Critically Ill Cancer Patients

  • Matthew ScharfEmail author
  • Niki Kasinathan
  • Jag Sunderram
Reference work entry


Sleep disorders are common in society and are common in patients with cancer. Patients with cancer frequently complain of sleep problems and daytime sleepiness. The diagnosis of cancer, cancer treatments, and psychological issues in dealing with a cancer diagnosis and treatment may cause sleep disruption. Furthermore, in the course of cancer treatment, many patients with cancer require intensive care unit (ICU) care which can cause additional sleep disruption. This sleep disruption in an ICU can be due to environmental factors, frequent interventions, and use of various sedative medications. Therefore, patients with cancer, particularly those requiring ICU care, commonly develop sleep problems. Treatment of sleep problems in these patients may improve the morbidity and possibly mortality associated with cancer.


Sleep Cancer Oncology ICU 


  1. 1.
    Porter VR, Buxton WG, Avidan AY. Sleep, cognition and dementia. Curr Psychiatry Rep. 2015;17:97. Scholar
  2. 2.
    Yaffe K, Falvey CM, Hoang T. Connections between sleep and cognition in older adults. Lancet Neurol. 2014;13:1017–28. Scholar
  3. 3.
    Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001;93:1557–62.CrossRefGoogle Scholar
  4. 4.
    Hansen J. Night shift work and risk of breast cancer. Curr Environ Health Rep. 2017;4:325–39. Scholar
  5. 5.
    Kubo T, et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol. 2006;164:549–55. Scholar
  6. 6.
    Nagai M, Hoshide S, Kario K. Sleep duration as a risk factor for cardiovascular disease- a review of the recent literature. Curr Cardiol Rev. 2010;6:54–61. Scholar
  7. 7.
    Patyar S, Patyar RR. Correlation between sleep duration and risk of stroke. J Stroke Cerebrovasc Dis. 2015;24:905–11. Scholar
  8. 8.
    Yin J, et al. Relationship of sleep duration with all-cause mortality and cardiovascular events: a systematic review and dose-response meta-analysis of prospective cohort studies. J Am Heart Assoc. 2017;6.
  9. 9.
    Zhai L, Zhang H, Zhang D. Sleep duration and depression among adults: a meta-analysis of prospective studies. Depress Anxiety. 2015;32:664–70. Scholar
  10. 10.
    Gottlieb DJ, Ellenbogen JM, Bianchi MT, Czeisler CA. Sleep deficiency and motor vehicle crash risk in the general population: a prospective cohort study. BMC Med. 2018;16:44. Scholar
  11. 11.
    Borbely AA, Daan S, Wirz-Justice A, Deboer T. The two-process model of sleep regulation: a reappraisal. J Sleep Res. 2016;25:131–43. Scholar
  12. 12.
    Sack RL, et al. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep. 2007a;30:1460–83.CrossRefGoogle Scholar
  13. 13.
    Sack RL, et al. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep. 2007b;30:1484–501.CrossRefGoogle Scholar
  14. 14.
    Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006–14. Scholar
  15. 15.
    Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:136–43. Scholar
  16. 16.
    Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007;3:S7–10.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10:541–53.CrossRefGoogle Scholar
  18. 18.
    Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.CrossRefGoogle Scholar
  19. 19.
    Roehrs TA, Randall S, Harris E, Maan R, Roth T. MSLT in primary insomnia: stability and relation to nocturnal sleep. Sleep. 2011;34:1647–52. Scholar
  20. 20.
    Ream E, Richardson A. Fatigue: a concept analysis. Int J Nurs Stud. 1996;33:519–29.CrossRefGoogle Scholar
  21. 21.
    Otte JL, et al. Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained? Cancer Med. 2015;4:183–200. Scholar
  22. 22.
    Roscoe JA, et al. Cancer-related fatigue and sleep disorders. Oncologist. 2007;12(Suppl 1):35–42. Scholar
  23. 23.
    Berger AM, et al. Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum. 2005;32:E98–126. Scholar
  24. 24.
    Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbance in cancer patients. Soc Sci Med. 2002;54:1309–21.CrossRefGoogle Scholar
  25. 25.
    Anderson KO, Getto CJ, Mendoza TR, Palmer SN, Wang XS, Reyes-Gibby CC, Cleeland CS. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manag. 2003;25:307–18.CrossRefGoogle Scholar
  26. 26.
    Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18:743–53. Scholar
  27. 27.
    Redeker NS, Lev EL, Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract. 2000;14:275–90; discussion 291–278PubMedGoogle Scholar
  28. 28.
    Beck SL, Dudley WN, Barsevick A. Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster. Oncol Nurs Forum. 2005;32:542. Scholar
  29. 29.
    Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001;28:465–70.PubMedGoogle Scholar
  30. 30.
    Given B, Given C, Azzouz F, Stommel M. Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment. Nurs Res. 2001;50:222–32.CrossRefGoogle Scholar
  31. 31.
    Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16:1689–96. Scholar
  32. 32.
    Collins KP, et al. Sleep duration is associated with survival in advanced cancer patients. Sleep Med. 2017;32:208–12. Scholar
  33. 33.
    Bartsch C, Bartsch H. Melatonin in cancer patients and in tumor-bearing animals. Adv Exp Med Biol. 1999;467:247–64.CrossRefGoogle Scholar
  34. 34.
    Khoory R, Stemme D. Plasma melatonin levels in patients suffering from colorectal carcinoma. J Pineal Res. 1988;5:251–8.CrossRefGoogle Scholar
  35. 35.
    Payne JK. The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy. Oncol Nurs Forum. 2002;29:1334–40. Scholar
  36. 36.
    Viviani S, Bidoli P, Spinazze S, Rovelli F, Lissoni P. Normalization of the light/dark rhythm of melatonin after prolonged subcutaneous administration of interleukin-2 in advanced small cell lung cancer patients. J Pineal Res. 1992;12:114–7.CrossRefGoogle Scholar
  37. 37.
    Ardestani SK, Inserra P, Solkoff D, Watson RR. The role of cytokines and chemokines on tumor progression: a review. Cancer Detect Prev. 1999;23:215–25.CrossRefGoogle Scholar
  38. 38.
    Ancoli-Israel S, et al. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study. Support Care Cancer. 2014;22:2535–45. Scholar
  39. 39.
    Cimprich B. Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs. 1999;22:185–94; quiz 195CrossRefGoogle Scholar
  40. 40.
    Savard J, Ivers H, Savard MH, Morin CM. Cancer treatments and their side effects are associated with aggravation of insomnia: Results of a longitudinal study. Cancer. 2015;121:1703–11. Scholar
  41. 41.
    Enderlin CA, et al. Sleep measured by polysomnography in patients receiving high-dose chemotherapy for multiple myeloma prior to stem cell transplantation. Oncol Nurs Forum. 2013;40:73–81. Scholar
  42. 42.
    Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24:583–90.CrossRefGoogle Scholar
  43. 43.
    Nesse W, Hoekema A, Stegenga B, van der Hoeven JH, de Bont LG, Roodenburg JL. Prevalence of obstructive sleep apnoea following head and neck cancer treatment: a cross-sectional study. Oral Oncol. 2006;42:108–14. Scholar
  44. 44.
    Payne RJ, et al. High prevalence of obstructive sleep apnea among patients with head and neck cancer. J Otolaryngol. 2005;34:304–11.CrossRefGoogle Scholar
  45. 45.
    Rosen GM, Bendel AE, Neglia JP, Moertel CL, Mahowald M. Sleep in children with neoplasms of the central nervous system: case review of 14 children. Pediatrics. 2003;112:e46–54.CrossRefGoogle Scholar
  46. 46.
    Kamdar BB, Needham DM, Collop NA. Sleep deprivation in critical illness: its role in physical and psychological recovery. J Intensive Care Med. 2012;27:97–111. Scholar
  47. 47.
    Matthews EE. Sleep disturbances and fatigue in critically ill patients. AACN Adv Crit Care. 2011;22:204–24. Scholar
  48. 48.
    Friese RS. Sleep and recovery from critical illness and injury: a review of theory, current practice, and future directions. Crit Care Med. 2008;36:697–705. Scholar
  49. 49.
    Beecroft JM, Ward M, Younes M, Crombach S, Smith O, Hanly PJ. Sleep monitoring in the intensive care unit: comparison of nurse assessment, actigraphy and polysomnography. Intensive Care Med. 2008;34:2076–83. Scholar
  50. 50.
    Elliott R, McKinley S, Cistulli P, Fien M. Characterisation of sleep in intensive care using 24-hour polysomnography: an observational study. Crit Care. 2013;17:R46. Scholar
  51. 51.
    Sforza E, Haba-Rubio J, De Bilbao F, Rochat T, Ibanez V. Performance vigilance task and sleepiness in patients with sleep-disordered breathing. Eur Respir J. 2004;24:279–85.CrossRefGoogle Scholar
  52. 52.
    Pulak LM, Jensen L. Sleep in the intensive care unit: a review. J Intensive Care Med. 2016;31:14–23. Scholar
  53. 53.
    Sunderram J, Sofou S, Kamisoglu K, Karantza V, Androulakis IP. Time-restricted feeding and the realignment of biological rhythms: translational opportunities and challenges. J Transl Med. 2014;12:79. Scholar
  54. 54.
    Hu RF, Jiang XY, Zeng YM, Chen XY, Zhang YH. Effects of earplugs and eye masks on nocturnal sleep, melatonin and cortisol in a simulated intensive care unit environment. Crit Care. 2010;14:R66. Scholar
  55. 55.
    Shilo L, et al. Patients in the intensive care unit suffer from severe lack of sleep associated with loss of normal melatonin secretion pattern. Am J Med Sci. 1999;317:278–81.CrossRefGoogle Scholar
  56. 56.
    Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B, Shenkman L. Effect of melatonin on sleep quality of COPD intensive care patients: a pilot study. Chronobiol Int. 2000;17:71–6.CrossRefGoogle Scholar
  57. 57.
    Berglund B, Lindvall T, Schwela DH (1999) Guidelines for Community Noise. World Health Organization: Protection of the Human Environment. Accessed 08 July 2018.
  58. 58.
    Darbyshire JL, Young JD. An investigation of sound levels on intensive care units with reference to the WHO guidelines. Crit Care. 2013;17:R187. Scholar
  59. 59.
    Christensen M. Noise levels in a general intensive care unit: a descriptive study. Nurs Crit Care. 2007;12:188–97. Scholar
  60. 60.
    Aaron JN, Carlisle CC, Carskadon MA, Meyer TJ, Hill NS, Millman RP. Environmental noise as a cause of sleep disruption in an intermediate respiratory care unit. Sleep. 1996;19:707–10.CrossRefGoogle Scholar
  61. 61.
    Freedman NS, Gazendam J, Levan L, Pack AI, Schwab RJ. Abnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unit. Am J Respir Crit Care Med. 2001;163:451–7. Scholar
  62. 62.
    Celik S, Oztekin D, Akyolcu N, Issever H. Sleep disturbance: the patient care activities applied at the night shift in the intensive care unit. J Clin Nurs. 2005;14:102–6. Scholar
  63. 63.
    Scharf MT, Kelz MB. Sleep and anesthesia interactions: a pharmacological appraisal. Curr Anesthesiol Rep. 2013;3:1–9. Scholar
  64. 64.
    Pandharipande PP, et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care. 2010;14:R38. Scholar
  65. 65.
    Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428–36.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Matthew Scharf
    • 1
    • 2
    Email author
  • Niki Kasinathan
    • 1
  • Jag Sunderram
    • 1
  1. 1.Department of Medicine, Division of Pulmonary and Critical CareRutgers-Robert Wood Johnson Medical SchoolNew BrunswickUSA
  2. 2.Department of NeurologyRutgers-Robert Wood Johnson Medical SchoolNew BrunswickUSA

Section editors and affiliations

  • Yenny Cardenas
    • 1
  1. 1.Critical Care DepartmentUniversidad del Rosario Hospital Universitario Fundacion Santa Fe deBogotaColombia

Personalised recommendations